Conventus Orthopaedics

What Conventus Orthopaedics does

Conventus Orthopaedics is a privately held US orthopedic medical device company that designs, manufactures, and sells specialty implants and sterile surgical solutions for fracture fixation and ligament repair. Founded in 2008 and headquartered in Maple Grove, Minnesota, the company built its identity around the FlexThread intramedullary nail platform, whose flexible-shaft design enables minimally invasive treatment of distal fibula and ulna fractures and osteotomies while accepting both flexible and rigid syndesmotic fixation. In May 2020, Conventus acquired Flower Orthopedics (Horsham, Pennsylvania), and the combined business now operates as Conventus Flower Orthopedics, a DBA of Flower Orthopedics Corporation, extending the portfolio to include the Constrictor knotless adjustable-button syndesmosis repair system, Ready-For-Surgery prepackaged sterile implant-and-instrument kits, plates, screws, and a biologics line.

The company sells exclusively through a direct enterprise field-sales motion targeting US orthopedic surgeons, hospital procurement teams, and surgical centers. Its revenue model is hardware sales of Class II/III orthopedic implants and consumables, with no disclosed pricing transparency beyond quote-based engagement through sales representatives. Customer-facing differentiators center on the FlexThread flexible nail architecture, claimed superior cyclic-loading and ultimate failure-to-load performance of the Constrictor versus the market leader, and the workflow efficiency of Ready-For-Surgery customizable sterile kits that reduce operating-room preparation time.

Operationally, Conventus has raised approximately $176M across ten funding rounds from 2013 through May 2020, with notable institutional participation from Deerfield Capital Management, Ally Bridge Group, BioStar Capital, Blue Sky Fund, Bluestem Capital, SightLine Partners, Oxford Finance, and Square 1 Bank. Headcount is reported in the 11-50 range. Leadership includes co-founder and CTO Paul Hindrichs, Executive Chairman Rick Epstein, CFO Jonathan Isenburg, VP of Marketing Tracy Martellotta, and VP of R&D and Operations Mike Mazzio. No public revenue, customer concentration, or geographic expansion data is disclosed.

Name

Conventus Orthopaedics

Legal name

Flower Orthopedics Corporation

Website

https://conventusortho.com

Company type

Private

Founded year

2008

Operating status

Operating

Headcount range

11–50 employees

Ownership category

akta.pro rank

NAICS

Surgical Appliance and Supplies Manufacturing (339113), Surgical and Medical Instrument Manufacturing (339112), Medical Equipment and Supplies Manufacturing (3391)

SIC

Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Orthopedic Trauma & Extremities Fixation (Plates/Screws/Nails/External Fixation) (HLAHAEAB)

Keywords

• Orthopedic implants
• Intramedullary nails
• Sports medicine devices
• Fracture fixation systems
• Sterile surgical solutions

Headquarters

HQ city

Maple Grove

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Technology or R&D, Operations, Personnel, Marketing or Sales, Infrastructure

Revenue model

1. Orthopedic implant and surgical device sales: Sale of intramedullary nails, syndesmosis repair systems, plates, screws, and biologics to healthcare providers and surgical centers. Revenue generated through direct sales of medical devices and surgical implants.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels2 records

Core offering

Conventus Orthopaedics (operating as Conventus Flower Orthopedics via Flower Orthopedics Corporation) designs, manufactures, and sells orthopedic surgical implants and fixation devices, including the FlexThread® intramedullary nail platform for fibula and ulna fractures, the Constrictor® knotless syndesmosis repair system for ankle ligament disruptions, and Ready-For-Surgery® prepackaged sterile implant and instrument kits. The company sells directly to orthopedic surgeons, hospitals, and surgical centers.

Product overview

Conventus Flower Orthopedics offers a portfolio of innovative orthopedic implant solutions organized around two core product lines: the FlexThread® IM Nail Platform (including Flex-Thread® Distal Fibula and Ulna Intramedullary Nails) for minimally invasive fracture treatment with flexible nail technology, and the Constrictor® Rope Syndesmosis Repair system for ankle ligament repair. These are complemented by the Ready-For-Surgery® Solutions line, which provides prepackaged, sterile-packaged plates, screws, and biologics for surgical procedures, enabling operating room efficiency with all required implants and instruments ready for use in standard or customizable configurations.

Differentiator

Problem solved

Functional benefit

Brands

• FlexThread®: Intramedullary nail platform for treatment of fibula and ulna fractures and osteotomies
• Constrictor®
• Ready-For-Surgery®

Quantifiable outcome

• Superior fixation under cyclic loading vs market leader (Constrictor)
• +1 more outcomes

Segments2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Recent moves6 records

Expansion highlights4 records

Direct peers

• Arthrex: Arthrex is the dominant player in sports medicine and extremity soft-tissue fixation. Its TightRope system is the cited 'market leader' in ankle syndesmosis repair — the exact competitive frame Conventus Flower's Constrictor is built to disrupt.
• Acumed: Acumed specializes in upper and lower extremity implants, including small-bone intramedullary nails and foot/ankle fixation. It is the most direct US-based comparable for the FlexThread distal fibula/ulna nail platform.
• Orthofix Medical: Orthofix is a focused extremity and spine orthopedic device company selling plates, screws, nails and biologics through a direct sales force. Its portfolio breadth in extremity trauma and biologics closely mirrors Conventus Flower's bundled offering.
• Paragon 28: Paragon 28 is a foot-and-ankle-focused orthopedic company with a sterile-pack / single-use instrumentation model that mirrors Conventus Flower's Ready-For-Surgery approach. It is a relevant direct comparable on both indication and packaging innovation.

Broad incumbents

• Stryker: Stryker is one of the largest orthopedic trauma and extremities competitors globally, with deep surgeon relationships, broad product breadth and the marketing/sales scale to rapidly neutralize niche entrants like Conventus Flower.
• Smith+Nephew: Smith+Nephew's Trauma & Extremities business competes across plates, screws, IM nails and ankle fixation. It is one of the major incumbents whose portfolio overlap and rep coverage set the competitive floor for Conventus Flower's commercial efforts.
• DePuy Synthes (Johnson & Johnson): DePuy Synthes is the historical category leader in orthopedic trauma, including IM nails and plates/screws. Its installed base, surgeon training programs and IDN contracts represent the biggest barrier to Conventus Flower's penetration of large hospital systems.
• Integra LifeSciences: Integra's Orthopedics and Tissue Technologies segment sells extremity fixation hardware and biologics through specialty channels. Its extremity focus and biologics overlap with Conventus Flower's portfolio make it a comparable mid-size peer.
• Enovis (DJO): Enovis, via DJO Surgical and its extremities portfolio, sells orthopedic implants including plates, screws and specialty fixation devices. Its broader portfolio and global reach make it a relevant comparable for Conventus Flower's commercial scaling trajectory.

Emerging players

• Treace Medical Concepts: Treace is an emerging foot-and-ankle-focused orthopedic company with proprietary implants and a direct sales model targeting a narrow set of indications — a useful comparison point on go-to-market and indication-narrow growth dynamics.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights5 records

Customer concentration

• LinkedInlinkedin.com/company/flower-orthopedics

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds10 records

Investors12 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Conventus Orthopaedics